Terje Arnulf Johansen • 1955 • Silsand • 17 roles • 23 shareholdings

Roles

Name	Role	Total operating income	Total equity	Shares
F FDV TROMS AS	Managing Director/CEO	7,782,689	1,198,813	90.1 % indirectly
L LYR INVEST AS	Managing Director/CEO	-	177,478,395	90.1 % directly
T TAJ EIENDOM AS	Managing Director/CEO	-	974,477	90.1 % indirectly
B BOLIGUTVIKLING SØR AS	Managing Director/CEO	-	508,870	90.1 % indirectly
T TAJ HOLDING AS	Managing Director/CEO	91,235,917	232,737,223	90.1 % indirectly
A ARELIA AS	Managing Director/CEO	-	-51,238	72.08 % indirectly

Name	Role	Total operating income	Total equity	Shares
C CAMPUS NORGE AS	Chairman	1,989,120	1,000,000	90.1 % indirectly
F FDV TROMS AS	Chairman	7,782,689	1,198,813	90.1 % indirectly
L LYR INVEST AS	Chairman	-	177,478,395	90.1 % directly
T TAJ EIENDOM AS	Chairman	-	974,477	90.1 % indirectly
B BOLIGUTVIKLING SØR AS	Chairman	-	508,870	90.1 % indirectly
T TAJ HOLDING AS	Chairman	91,235,917	232,737,223	90.1 % indirectly
A ARELIA AS	Chairman	-	-51,238	72.08 % indirectly
A ANS BYGG I NORD Closed	Participant with Joint and Several Liability (Full Responsibility)	-	-	-
A ALPINBYEN AS	Chairman	-	11,316,128	-

Last update: Jul 22, 2025

Name	Share class	Total operating income	Total equity	Share
A AKER ASA	NO0010234552	0	18,422,000,000	< 0.01 % directly
L LYR INVEST AS	A-aksjer B-aksjer	0 0	177,478,395 177,478,395	45.05 % directly 90.1 % 45.05 % directly 90.1 %
C CAMPUS NORGE AS		1,989,120	1,000,000	90.1 % indirectly
F FDV TROMS AS		7,782,689	1,198,813	90.1 % indirectly
T TAJ EIENDOM AS		0	974,477	90.1 % indirectly
B BOLIGUTVIKLING SØR AS		0	508,870	90.1 % indirectly
T TAJ HOLDING AS		91,235,917	232,737,223	90.1 % indirectly
T TJ EIENDOM AS		0	13,405,260	85.6 % indirectly
A ARELIA AS		0	-51,238	72.08 % indirectly
N NORSK EIENDOM OG UTVIKLING AS		0	2,014,290	27.03 % indirectly
A AMICOAT AS		7,009,939	63,759,267	10.47 % indirectly
P PEPTIDE PATENTS AS		900,336	697,496	10.47 % indirectly
P PHARMA HOLDINGS AS		120,000	8,158,078	10.47 % indirectly
N NORTH ENERGY ASA		90,000	390,321,000	1.42 % indirectly
N NORTH INDUSTRIES 2 AS		0	68,172,419	1.42 % indirectly
N NORTH INDUSTRIES 1 AS		0	189,299,565	1.42 % indirectly
P PHARMASUM THERAPEUTICS AS		989,892	-25,575	1.3 % indirectly
O OBSERVE MEDICAL ASA		3,974,000	7,952,000	1.09 % indirectly
O OBSERVE MEDICAL AS		0	-17,415,115	1.09 % indirectly
B BIIM ULTRASOUND AS Under liquidation		125,290	-51,214,871	1.09 % indirectly
L LYTIX BIOPHARMA ASA	NO0010405780	11,134,000	107,894,000	0.12 % directly 0.12 % indirectly 9.11 %
T TGS ASA	NO0003078800	192,586,000	942,409,000	0.05 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025